Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion type Assertion NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_head.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion description "[As a result, we found that the mRNA levels of FCMR in the CLL patients are 23-fold higher than that of the control group and this may suggest that it can be associated with the disease progression and survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_provenance.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion evidence source_evidence_literature NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_provenance.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion SIO_000772 21264533 NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_provenance.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion wasDerivedFrom befree-2016 NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_provenance.
- NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_assertion wasGeneratedBy ECO_0000203 NP867529.RAIekqwQ3iypEL39eeaqBUFxcIWDMimlbJCirvfO3yryk130_provenance.